Wanlu Qu

Wanlu Qu is a Principal Scientist at Amgen, leading analytical development activities on challenging late-stage programs and supervising master and PhD level scientists. Previously, they worked at Novartis Institutes for BioMedical Research, where they served as a Bioanalysis SME for diverse modalities, supporting preclinical and pivotal clinical trials while developing and validating various assays. Wanlu has extensive experience in method development, regulatory submission preparation, and project management, with a strong background in bioanalysis and CMC processes. They earned a Ph.D. in Chemistry and Chemical Biology from Northeastern University and were a postdoctoral fellow at Harvard's Forsyth Institute, focusing on disease diagnostics through proteomics.